|
|
|
|
|
|
Sponsored by: |
Agency for Healthcare Research and Quality (AHRQ) |
Information provided by: | Agency for Healthcare Research and Quality (AHRQ) |
ClinicalTrials.gov Identifier: | NCT00243360 |
The purpose of this study was to determine if a multi-faceted intervention to implement diagnostic and therapeutic algorithms for management of suspected urinary infection in nursing home residents could reduce antibiotic prescribing for urinary indications in this population.
Condition | Intervention |
Urinary Tract Infection, Antibiotic Use |
Behavioral: diagnostic and treatment clinical algorithms |
MedlinePlus related topics: | Antibiotics Urinary Tract Infections |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Optimizing Antibiotic Use in Long Term Care |
Study Start Date: | January 2001 |
Estimated Study Completion Date: | July 2003 |
Antibiotic use is intense in nursing homes and frequently inappropriate when prescribed for urinary indications. Evidence from randomized controlled trials suggests that treatment of asymptomatic bacteriuria, the presence of bacteria in the urine in the absence of urinary symptoms, is not beneficial. Despite this, one in three prescriptions for urinary indications are for asymptomatic bacteriuria. To improve antibiotic prescribing in this setting we conducted a cluster randomized trial of a strategy to implement diagnostic and treatment algorithms for urinary infection. 24 nursing homes were randomized to either the intervention (implemented at the nursing home level using a multi-faceted approach: small group interactive sessions for nurses, one-on-one interviews for physicians, videotapes, written material, and outreach visits) or to usual care.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Nursing homes
Exclusion Criteria:
-
Study ID Numbers: | U18 HS11113-01 |
First Received: | October 21, 2005 |
Last Updated: | October 21, 2005 |
ClinicalTrials.gov Identifier: | NCT00243360 |
Health Authority: | United States: Federal Government; Canada: Health Canada |
|
|
|